perflubron has been researched along with Neoplasms in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (33.33) | 18.2507 |
| 2000's | 3 (16.67) | 29.6817 |
| 2010's | 9 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, L; Li, X; Liang, X; Wang, F; Zhang, X | 1 |
| Ge, S; Han, B; Hu, Y; Jiang, J; Li, K; Liu, Y; Wang, Y; Xu, Y; Yin, F; Zhang, L; Zhang, S | 1 |
| Boissenot, T; Bordat, A; Chacun, H; Fattal, E; Larrat, B; Paci, A; Poinsignon, V; Tsapis, N; Varna, M | 1 |
| Ding, J; Liang, Q; Luo, S; Ma, X; Rong, P; Wang, P; Wang, W; Wang, Z; Yang, C | 1 |
| Guo, Q; Jing, F; Li, X; Sui, Z; Sun, J; Xu, W | 1 |
| Delplace, V; Diou, O; Fattal, E; Mackiewicz, N; Mériaux, S; Nicolas, J; Robic, C; Tsapis, N; Valette, J | 1 |
| Dai, Z; Jin, Y; Ke, H; Tian, J; Wang, J; Wang, S; Xing, S; Yue, X; Zhang, Q | 1 |
| Ke, H; Li, Z; Miao, Z; Wang, J; Yue, X | 1 |
| Dewhirst, MW; Hauck, ML; Snyder, SA | 1 |
| Chang, TM | 1 |
| Guichard, M; Lambin, P; Lartigau, E; Le Ridant, AM; Luboinski, B; Lusinchi, A; Martin, L; Thomas, C; Weeger, P; Wibault, P | 1 |
| Behan, M; Carney, DN; Mattrey, RF; O'Connell, D | 1 |
| Goldberg, BB | 1 |
| Lowe, KC | 1 |
| Adams, GE; Counsell, C; Thomas, C; Wood, P | 1 |
| Guichard, M; Riess, J; Thomas, C | 1 |
| Guichard, M | 1 |
| Chen, J; Dong, X; He, Q; Hu, Y; Jing, H; Liu, T; Yang, B; Zhou, X | 1 |
5 review(s) available for perflubron and Neoplasms
| Article | Year |
|---|---|
Perfluorooctylbromide nanoparticles for ultrasound imaging and drug delivery.
Topics: Animals; Atherosclerosis; Contrast Media; Drug Carriers; Drug Delivery Systems; Fluorocarbons; Humans; Hydrocarbons, Brominated; Nanoparticles; Neoplasms; Ultrasonography | 2018 |
The role of hypoxia in canine cancer.
Topics: Animals; Cell Hypoxia; Dog Diseases; Dogs; Fluorocarbons; Hydrocarbons, Brominated; Neoplasms | 2008 |
Oxygen carriers.
Topics: Animals; Antioxidants; Blood Substitutes; Clinical Trials as Topic; Fluorocarbons; Humans; Hydrocarbons, Brominated; Neoplasms; Nitric Oxide; Oxygen; Recombinant Proteins | 2002 |
Ultrasound contrast agents.
Topics: Albumins; Animals; Colloids; Contrast Media; Echocardiography; Emulsions; Fluorocarbons; Humans; Hydrocarbons, Brominated; Microspheres; Neoplasms; Polysaccharides; Ultrasonography | 1993 |
The use of fluorocarbon emulsions in cancer radiotherapy.
Topics: Blood Substitutes; Combined Modality Therapy; Drug Combinations; Emulsions; Fluorocarbons; Humans; Hydrocarbons, Brominated; Hydroxyethyl Starch Derivatives; Neoplasms; Plasma Substitutes; Radiation-Sensitizing Agents | 1991 |
13 other study(ies) available for perflubron and Neoplasms
| Article | Year |
|---|---|
Activatable near infrared dye conjugated hyaluronic acid based nanoparticles as a targeted theranostic agent for enhanced fluorescence/CT/photoacoustic imaging guided photothermal therapy.
Topics: Animals; Benzoates; Carbocyanines; Cell Survival; Female; Fluorescent Dyes; Fluorocarbons; HT29 Cells; Humans; Hyaluronic Acid; Hydrocarbons, Brominated; Hyperthermia, Induced; Indoles; Mice; Mice, Inbred BALB C; Multimodal Imaging; Nanoparticles; Neoplasms; Optical Imaging; Particle Size; Photoacoustic Techniques; Phototherapy; Theranostic Nanomedicine; Tissue Distribution; Tomography, X-Ray Computed | 2017 |
Folate receptor-targeted ultrasonic PFOB nanoparticles: Synthesis, characterization and application in tumor-targeted imaging.
Topics: Animals; Cell Line, Tumor; Contrast Media; Fluorocarbons; Folate Receptors, GPI-Anchored; Folic Acid; Humans; Hydrocarbons, Brominated; Liposomes; Male; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Neoplasms; Optical Imaging; Polyethylene Glycols; Ultrasonography | 2017 |
Ultrasound-induced mild hyperthermia improves the anticancer efficacy of both Taxol® and paclitaxel-loaded nanocapsules.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Combined Modality Therapy; Female; Fluorocarbons; Hydrocarbons, Brominated; Hyperthermia, Induced; Mice, Nude; Nanocapsules; Neoplasms; Paclitaxel; Polyethylene Glycols; Polyglactin 910; Tissue Distribution; Treatment Outcome; Ultrasonic Therapy | 2017 |
Carboxyl of Poly(D,L-lactide-co-glycolide) Nanoparticles of Perfluorooctyl Bromide for Ultrasonic Imaging of Tumor.
Topics: Capsules; Fluorocarbons; Humans; Hydrocarbons, Brominated; Nanoparticles; Neoplasms; Optical Imaging; Polylactic Acid-Polyglycolic Acid Copolymer; Ultrasonography | 2018 |
RGD decoration of PEGylated polyester nanocapsules of perfluorooctyl bromide for tumor imaging: influence of pre or post-functionalization on capsule morphology.
Topics: Animals; Cell Line, Tumor; Contrast Media; Cryoelectron Microscopy; Female; Fluorine-19 Magnetic Resonance Imaging; Fluorocarbons; Hydrocarbons, Brominated; Mice, Nude; Microscopy, Electron, Transmission; Nanocapsules; Neoplasms; Oligopeptides; Particle Size; Polyethylene Glycols; Surface Properties | 2014 |
Gold nanoshelled liquid perfluorocarbon nanocapsules for combined dual modal ultrasound/CT imaging and photothermal therapy of cancer.
Topics: Animals; Biocompatible Materials; Cell Line, Tumor; Cell Survival; Contrast Media; Fluorocarbons; Gold; Human Umbilical Vein Endothelial Cells; Humans; Hydrocarbons, Brominated; Hyperthermia, Induced; Mice; Multimodal Imaging; Nanocapsules; Nanoshells; Neoplasms; Particle Size; Phototherapy; Polyethylene Glycols; Spectrophotometry, Ultraviolet; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonics | 2014 |
Graphene Oxide and Gadolinium-Chelate Functionalized Poly(lactic acid) Nanocapsules Encapsulating Perfluorooctylbromide for Ultrasound/Magnetic Resonance Bimodal Imaging Guided Photothermal Ablation of Cancer.
Topics: Biocompatible Materials; Chelating Agents; Fluorocarbons; Gadolinium; Graphite; HeLa Cells; Human Umbilical Vein Endothelial Cells; Humans; Hydrocarbons, Brominated; Hyperthermia, Induced; Lactic Acid; Magnetic Resonance Imaging; Nanocapsules; Neoplasms; Oxides; Phototherapy; Polyesters; Polymers; Ultrasonography | 2016 |
Tumor oxygenation after 1) carbogen and/or perflubron emulsion administration in tumor xenografts 2) carbogen administration in patients.
Topics: Administration, Inhalation; Animals; Carbon Dioxide; Drug Therapy, Combination; Emulsions; Fluorocarbons; Hydrocarbons, Brominated; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms; Oxygen; Partial Pressure; Radiation-Sensitizing Agents; Transplantation, Heterologous | 1994 |
Perfluorooctylbromide as a contrast agent for CT and sonography: preliminary clinical results.
Topics: Adult; Aged; Aortography; Contrast Media; Female; Fluorocarbons; Humans; Hydrocarbons, Brominated; Liver; Liver Neoplasms; Male; Middle Aged; Neoplasms; Spleen; Tomography, X-Ray Computed; Ultrasonography; Vena Cava, Inferior | 1993 |
Substitutes for blood.
Topics: Angioplasty, Balloon; Blood Loss, Surgical; Blood Substitutes; Clinical Trials as Topic; Emulsions; Fluorocarbons; Hemoglobins; Humans; Hydrocarbons, Brominated; Neoplasms; Recombinant Proteins; Solutions | 2001 |
Use of fluorine-19 nuclear magnetic resonance spectroscopy and hydralazine for measuring dynamic changes in blood perfusion volume in tumors in mice.
Topics: Animals; Carcinoma, Squamous Cell; Fluorine; Fluorocarbons; Hydralazine; Hydrocarbons, Brominated; Magnetic Resonance Spectroscopy; Melanoma; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms; Regional Blood Flow; Sarcoma; Tumor Cells, Cultured; Xenon Radioisotopes | 1992 |
Influence of the 100% w/v perfluorooctyl bromide (PFOB) emulsion dose on tumour radiosensitivity.
Topics: Adenocarcinoma; Animals; Carbon Dioxide; Colonic Neoplasms; Combined Modality Therapy; Fluorocarbons; Humans; Hydrocarbons, Brominated; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms; Oxygen; Radiation-Sensitizing Agents; Rectal Neoplasms; Transplantation, Heterologous | 1991 |
Pharmacophore identification, virtual screening and biological evaluation of prenylated flavonoids derivatives as PKB/Akt1 inhibitors.
Topics: 3-Phosphoinositide-Dependent Protein Kinases; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Drug Design; Flavonoids; Humans; Models, Molecular; Neoplasms; Prenylation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt | 2011 |